Effectiveness of Web-based Treatment for Depression in Patients With Neurologic Disorders
Depression

About this trial
This is an interventional treatment trial for Depression focused on measuring Depression, Online-Therapy, Deprexis, Self-help
Eligibility Criteria
Inclusion Criteria:
- presence of a confirmed diagnosis of multiple sclerosis or epilepsy
- self-reported urge to be treated for depressive symptoms (no externally confirmed diagnosis necessary)
- informed consent (provided online in line with regulations by the Hamburg Department of Data Security)
Exclusion Criteria:
- unable to provide informed consent
- diagnosis of bipolar or schizophrenia spectrum disorders
- substantial neurocognitive impairment (e.g. dementia)
- acute suicidal tendencies as assessed with the Suicide Behaviors Questionnaire-Revised (SBQ-R). Subjects excluded for this reason are provided various emergency contacts and phone numbers.
Sites / Locations
- University Medical Center Hamburg-Eppendorf - Neurology
- Epilepsy Centre Alsterdorf
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Deprexis
Wait-list
Deprexis (Web-based intervention deprexis consists of ten online modules (plus one introductory and one summary module) representing different psychotherapeutic strategies with a strong focus on evidence-based cognitive-behavioral techniques (e.g. interpersonal skills). Each module lasts approximately 10-60 minutes (e.g. depending on the user´s reading speed). Modules are sequential and organized as simulated dialogues. Each module refers and builds upon previous one. The program is delivered at no cost to participants.)
Wait-list group (Subjects receive access to deprexis after six months)